Skip to content

Surgical Approach in Liver Hemangiomas

Surgical Approach in Liver Hemangiomas With Special Emphasis on Lesion Diameter and Type of Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04669314
Enrollment
69
Registered
2020-12-16
Start date
2020-10-01
Completion date
2020-10-30
Last updated
2020-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemangioma Liver

Keywords

hemangioma, liver resection, enucleation

Brief summary

Operations performed for liver hemangioma between January 2017 and December 2018 will be retrospectively analyzed.

Detailed description

Operations performed for liver hemangioma at Ankara University Hospitals will be retrospectively analyzed. Patient and disease characteristics including demographics, laboratory tests, imaging studies, type of surgical approach and outcomes including postoperative laboratory tests, record of complications, duration of hospital stay will be reviewed. Complications were classified according to Clavien-Dindo classification. The patients were informed about the surgeries in advance and their informed consents about surgeries and data collection for scientific purposes were obtained. Datafile will be anonymized before analysis and original file will be destroyed. Outcomes such as complications, hospital stay, blood transfusion and mortality will be compared between groups created according to type of surgery, lesion size, preoperative laboratory values and demographic features. Variables for prediction of better outcomes are expected to be discovered.

Interventions

PROCEDURELiver resection or enucleation for liver hemangioma

Operations in which the hemangioma is selectively removed from the liver parenchyma border are named enucleation, and the operations in which the hemangioma is removed anatomically or non-anatomically with some liver parenchyma surrounding it are named liver resection

Sponsors

Ankara University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients underwent surgery for liver hemangioma

Exclusion criteria

* Cases lacking of more than 20% of critical data

Design outcomes

Primary

MeasureTime frameDescription
ComplicationsComplications reported within 3 months after surgery will be evaluated within 15 days after completion of data collectionComplications after surgery for hemangioma will be collected from records and and will be classified according to 'The Clavien-Dindo Classification of Surgical Complications'. The classification grades are ranging between Grade 1(better) which indicates minor deviation from normal postoperative course and Grade 5 (worst) which means death as a complication.

Secondary

MeasureTime frameDescription
Hospital stayHospital stay starting with operation and ends with discharge will be compared within 15 days after completion of data collectionLength of hospital stay postoperatively
TransfusionErythrocyte transfusion during surgery will be analyzed within 15 days after completion of data collectionRate of erythrocyte transfusion

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026